Grace Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-ADAR1 Capital Management, LLC(9.99%),ADAR1 Capital Management GP, LLC(9.99%)等
Grace Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-BANK OF AMERICA CORP /DE/(4.9%)
Acasti Pharma | 3/A:首次持股聲明(修正)-股東 ADAR1 Capital Management, LLC
Acasti Pharma | SC 13G:超過5%持股股東披露文件-ADAR1 Capital Management, LLC(10.20%),ADAR1 Capital Management GP, LLC(10.20%)等
Acasti Pharma | 3:首次持股聲明-股東 ADAR1 Capital Management, LLC
Acasti Pharma | 4/A:持股變動聲明(修正)-高管 D'Andrea Carrie
Acasti Pharma | 4/A:持股變動聲明(修正)-高管 Kumar Amresh
Acasti Pharma | 4:持股變動聲明-高管 D'Andrea Carrie
Acasti Pharma | 4:持股變動聲明-高管 Kumar Amresh
Acasti Pharma | 4:持股變動聲明-高管 Macdonald R. Loch
Acasti Pharma | 4:持股變動聲明-高管 DelAversano Robert J
Acasti Pharma | 4:持股變動聲明-高管 Kohli Prashant
Acasti Pharma | SC 13G:超過5%持股股東披露文件-AIGH Capital Management, LLC(6.0%),Orin H(6.0%)
Acasti Pharma | SC 13G:超過5%持股股東披露文件-BANK OF AMERICA CORPORATION(5.3%)
Acasti Pharma | 3:首次持股聲明-高管 DelAversano Robert J
Acasti Pharma | 4:持股變動聲明-董事 Kavuru Vimal
Acasti Pharma | 4:持股變動聲明-董事 Kottayil George
Acasti Pharma | 4:持股變動聲明-董事 NEUGEBOREN EDWARD
Acasti Pharma | 4:持股變動聲明-董事 DAVIS A BRIAN
Acasti Pharma | 4:持股變動聲明-首席執行官 Kohli Prashant